棘球蚴病患者肠道菌群差异性分析

doi:10.12140/j.issn.1000-7423.2023.01.016

中国寄生虫学与寄生虫病杂志 ›› 2023, Vol. 41 ›› Issue (1): 103-107.doi: 10.12140/j.issn.1000-7423.2023.01.016

棘球蚴病患者肠道菌群差异性分析

曹得萍¹(), 毋德芳², 庞明泉²^,³, 彭小红¹, 李大宇¹, 樊海宁²^,³^,^*()

1.桂林医学院基础医学院人体寄生虫学教研室，广西桂林 541199
2.青海省包虫病重点实验室，西宁 810001
3.青海大学附属医院肝胆胰外科，西宁 810000

收稿日期:2022-04-14 修回日期:2022-10-09 出版日期:2023-02-28 发布日期:2023-02-22
通讯作者: * 樊海宁（1970-），男，硕士，主任医师，从事肝胆胰疾病外科治疗和包虫病临床研究。Email：fanhaining@medmail.com.cn
作者简介:曹得萍（1970-），女，博士，教授，从事人体寄生虫学教学和包虫病分子生物学研究，Email：qhmccdp@163.com
基金资助:
国家自然科学基金(NSFC 8196057);青海省科技厅项目(2019-SF-131)

Difference analysis of the gut microbiome in patients with echinococcosis

CAO Deping¹(), WU Defang², PANG Mingquan²^,³, PENG Xiaohong¹, LI Dayu¹, FAN Haining²^,³^,^*()

1. Department of Human Parasitology, Basic Medical College, Guilin Medical University, Guilin 541199, Guangxi, China
2. Qinghai Research Key Laboratory for Echinococcosis, Xining 810001, China
3. Department of Hepatopancreatobiliary Surgery, Affiliated Hospital of Qinghai University, Xining 810000, China

Received:2022-04-14 Revised:2022-10-09 Online:2023-02-28 Published:2023-02-22
Contact: * E-mail: fanhaining@medmail.com.cn
Supported by:
National Natural Science Foundation of China(NSFC 8196057);Qinghai Science and Technology Department Project(2019-SF-131)

摘要/Abstract

摘要：

2020年10—12月在青海大学附属医院肝胆外科收集13例棘球蚴患者（其中7例多房棘球蚴病、6例细粒棘球蚴病，为感染组）与13例护理患者健康家属（为对照组）的粪样。提取粪样DNA并测定浓度，逆转录合成cDNA文库，利用宏基因组二代测序平台进行测序。用线性判别分析统计棘球蚴病患者与健康对照组之间肠道菌群的差异性。结果显示，棘球蚴病患者与健康对照组肠道菌群属于厚壁菌门、拟杆菌群门、变形菌门及放线菌门等。多房棘球蚴组相对丰度较高的细菌是另枝菌、拟杆菌，细粒棘球蚴组相对丰度较高的细菌是另枝菌、史氏甲烷短杆菌、前庭链球菌。健康对照组相对丰度较高的细菌是粪拟杆菌、青春双歧杆菌、琥珀酸考拉杆菌。其中另枝菌和粪拟杆菌是差异较大的细菌。本研究中的差异菌群或许可成为棘球蚴病肠道微生物标志菌，值得进一步研究。

关键词: 棘球蚴病, 肠道菌群, 多样性, 宏基因组测序

Abstract:

Fecal samples of 13 patients (7 patients with alveolar echinococcosis, 6 patients with cystic echinococcosis as infected group) and 13 healthy family members caring for patients (as control group) were collected in the Department of Hepatobiliary Surgery of Qinghai University Affiliated Hospital from October to December in 2020. The fecal DNA was extracted and the concentration was determined, and the cDNA library was synthesized by reverse transcription, and then sequenced using the metagenomic next generation sequencing. The metagenome second-generation sequencing was used to observe the changes of intestinal flora. Linear discriminant analysis was used to analyse the differences in intestinal flora between echinococcosis patients and healthy controls. The results revealed that the flora with higher relative abundance in the alveolar echinococcosis group were Alistipes onderdonkii, Bacteroides dorei, A. finegoldii, and the flora with higher relative abundance in the cystic echinococcosis group were A. shahii, Methanobrevibacter smithii, Streptococcus vestibularis. In the healthy individuals group, there were high relative abundance of B. caccae, Bifidobacterium adolescentis, Phascolarctobacterium succinatutens. Among them, A. onderdonkii, A. shahii and B. caccae are more meaningful flora. The differential flora in this study may be the intestinal microbial marker of echinococcosis, which deserves further to study.

Key words: Echinococcosis, Gut Microbiome, Diversity, Metagenomic next generation sequencing

中图分类号:

R532.32

曹得萍, 毋德芳, 庞明泉, 彭小红, 李大宇, 樊海宁. 棘球蚴病患者肠道菌群差异性分析[J]. 中国寄生虫学与寄生虫病杂志, 2023, 41(1): 103-107.

CAO Deping, WU Defang, PANG Mingquan, PENG Xiaohong, LI Dayu, FAN Haining. Difference analysis of the gut microbiome in patients with echinococcosis[J]. Chinese Journal of Parasitology and Parasitic Diseases, 2023, 41(1): 103-107.

图/表 2

参考文献 20

[1]	Wu ZD, Zhu XP. Human parasitology[M]. 3rd ed. Beijing: People’s Medical Publishing House, 2015: 214-216. (in Chinese)
	(吴忠道, 诸欣平. 人体寄生虫学[M]. 3版. 北京: 人民卫生出版社, 2015: 214-216.)
[2]	Wen H, Vuitton L, Tuxun T, et al. Echinococcosis: Advances in the 21st century[J]. Clin Microbiol Rev, 2019, 32(2): e00075-e00018.
[3]	Sender R. Are we really vastly outnumbered? revisiting the ratio of bacterial to host cells in humans[J]. Cell, 2016, 164(3): 337-340.
[4]	Gui QF, Jin HL, Zhu F, et al. Gut microbiota signatures in Schistosoma japonicum infection-induced liver cirrhosis patients: a case-control study[J]. Infect Dis Poverty, 2021, 10: 43.
[5]	Schroeder BO, B?ckhed F. Signals from the gut microbiota to distant organs in physiology and disease[J]. Nat Med, 2016, 22(10): 1079-1089.
[6]	Schluter J, Peled JU, Taylor BP, et al. The gut microbiota is associated with immune cell dynamics in humans[J]. Nature, 2020, 588(7837): 303-307.
[7]	Qin N, Yang FL, Li A, et al. Alterations of the human gut microbiome in liver cirrhosis[J]. Nature, 2014, 513(7516): 59-64.
[8]	Zhao Y, Yang S, Li B, et al. Alterations of the mice gut microbiome via Schistosoma japonicum Ova-induced granuloma[J]. Front Microbiol, 2019, 10: 352.
[9]	Expert consensus on diagnosis and treatment of hepatic cystic and alveolar echinococcosis (2019 edition)[J]. Chin J Dig Surg, 2019, 18(8): 711-721. (in Chinese)
	(中国医师协会外科医师分会包虫病外科专业委员会. 肝两型包虫病诊断与治疗专家共识(2019版)[J]. 中华消化外科杂志, 2019, 18(8): 711-721.)
[10]	Menzel P, Ng KL, Krogh A. Fast and sensitive taxonomic classification for metagenomics with Kaiju[J]. Nat Commun, 2016, 7: 11257.
[11]	Eckburg PB, Bik EM, Bernstein CN, et al. Diversity of the human intestinal microbial flora[J]. Science, 2005, 308(5728): 1635-1638.
[12]	Kazemian N, Mahmoudi M, Halperin F, et al. Gut microbiota and cardiovascular disease: Opportunities and challenges[J]. Microbiome, 2020, 8(1): 36.
[13]	Wu YH. Variations in fecal microbial profiles of acute exacerbations and stable chronic obstructive pulmonary disease[J]. Life Sci, 2021, 265: 118738.
[14]	Bajaj JS. Altered profile of human gut microbiome is associated with cirrhosis and its complications[J]. J Hepatol, 2014, 60(5): 940-947.
[15]	Minemura M. Gut microbiota and liver diseases[J]. World J Gastroenterol, 2015, 21(6): 1691.
[16]	Jakobsson HE, Rodríguez-Pi?eiro AM, Schütte A, et al. The composition of the gut microbiota shapes the colon mucus barrier[J]. EMBO Rep, 2015, 16(2): 164-177.
[17]	Tyrrell KL. Re-assessment of phenotypic identifications of Bacteroides putredinis to Alistipes species using molecular methods[J]. Anaerobe, 2011, 17(3): 130-134.
[18]	Parker BJ, Wearsch PA, Veloo ACM, et al. The genus Alistipes: gut bacteria with emerging implications to inflammation, cancer, and mental health[J]. Front Immunol, 2020, 11: 906.
[19]	Nakajima A, Sasaki T, Itoh K, et al. A soluble fiber diet increases Bacteroides fragilis group abundance and immunoglobulin A production in the gut[J]. Appl Environ Microbiol, 2020, 86(13): 405-420.
[20]	Wei B, Dalwadi H, Gordon LK, et al. Molecular cloning of a Bacteroides caccae TonB-linked outer membrane protein identified by an inflammatory bowel disease marker antibody[J]. Infect Immun, 2001, 69 (10): 6044-6054.

棘球蚴病患者肠道菌群差异性分析

Difference analysis of the gut microbiome in patients with echinococcosis

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

图/表 2

参考文献 20

相关文章 15

编辑推荐

Metrics

本文评价

[1]	杨晚璇, 沈海默, 陈绅波, 陈军虎. 间日疟原虫VIR14蛋白与ICAM-1受体相互作用关键位点分析[J]. 中国寄生虫学与寄生虫病杂志, 2025, 43(2): 192-197.
[2]	史光忠, 尹哲, 亚里昆·买买提依明, 买买提江·吾买尔, 开赛尔·吐尔逊江, 程侠, 赵江山. 2023年新疆棘球蚴病流行特征及空间格局分析[J]. 中国寄生虫学与寄生虫病杂志, 2025, 43(2): 231-235.
[3]	韩帅, 李石柱. 我国棘球蚴病流行现状及重点防治工作思考[J]. 中国寄生虫学与寄生虫病杂志, 2025, 43(1): 1-5.
[4]	王莹, 刘白雪, 王旭, 王立英, 薛垂召, 蒉嫣, 杨诗杰, 伍卫平, 韩帅. 全国棘球蚴病参比实验室网络建设进展[J]. 中国寄生虫学与寄生虫病杂志, 2025, 43(1): 119-123.
[5]	周檀芳, 朱江, 徐心路, 祖力皮喀尔·图孙尼亚孜, 卡力比夏提·艾木拉江, 温浩. Toll样受体介导的宿主免疫应答在棘球蚴病中的研究进展[J]. 中国寄生虫学与寄生虫病杂志, 2025, 43(1): 124-128.
[6]	廖沙, 张仲双, 杨柳, 喻文杰, 何伟, 张光葭, 姚人新, 李汭芮, 黄燕, 王谦. 2021—2023年四川省棘球蚴病监测结果分析[J]. 中国寄生虫学与寄生虫病杂志, 2025, 43(1): 14-19.
[7]	罗文博, 雷霞, 韩松, 张宇耕, 燕鸽, 跃华, 姜晓峰. 内蒙古2015—2023年棘球蚴病病例特征分析[J]. 中国寄生虫学与寄生虫病杂志, 2025, 43(1): 140-142.
[8]	刘校伸, 王灏, 杜磊, 樊海宁, 郭新建, 马倩源, 任利. 误诊为胰腺浆液性囊腺瘤的胰腺细粒棘球蚴病1例[J]. 中国寄生虫学与寄生虫病杂志, 2025, 43(1): 152-154.
[9]	李奔福, 吴方伟, 字金荣, 严信留, 彭佳, 王正青, 李建雄, 徐倩, 李永飞, 杨亚明. 2017—2023年云南省棘球蚴病综合防治措施实施效果分析[J]. 中国寄生虫学与寄生虫病杂志, 2025, 43(1): 20-25.
[10]	韩松, 雷霞, 聂莉, 罗文博, 姜晓峰. 内蒙古自治区棘球蚴病流行基线抽样调查与分析[J]. 中国寄生虫学与寄生虫病杂志, 2025, 43(1): 26-29.
[11]	吴向林, 刘煊, 马国良, 段红菊, 马天宝, 田慧芳, 王志平, 齐蓉婷, 闫芳. 宁夏多房棘球蚴病流行区流浪犬和野外犬科动物驱虫方法的探索与效果评估[J]. 中国寄生虫学与寄生虫病杂志, 2025, 43(1): 30-36.
[12]	张仲双, 张光葭, 姚人新, 杨柳, 喻文杰, 何伟, 廖沙, 黄燕, 王谦. 四川省棘球蚴病疫点传播风险评估体系构建研究[J]. 中国寄生虫学与寄生虫病杂志, 2025, 43(1): 37-43.
[13]	雷家希, 贡桑曲珍, 王立英, 杨频, 程茜茜, 王芝依, 姜明哲. 2015—2022年西藏棘球蚴病人群筛查和患者治疗成本效果分析[J]. 中国寄生虫学与寄生虫病杂志, 2025, 43(1): 44-51.
[14]	刘白雪, 蒉嫣, 薛垂召, 王旭, 王莹, 王立英, 杨诗杰, 韩帅, 许学年. 2023年全国棘球蚴病防治工作进展[J]. 中国寄生虫学与寄生虫病杂志, 2025, 43(1): 6-13.
[15]	邓冰清, 阿迪莱·多力坤, 李寅时, 阿比旦·艾尼瓦尔, 孙胜, 肖雯颖, 葛聪蕙, 唐娜, 姜涛, 王慧, 张传山, 李静. 多房棘球蚴感染小鼠腹膜腔免疫细胞迁移及其功能变化[J]. 中国寄生虫学与寄生虫病杂志, 2025, 43(1): 76-83.